-
Our Mission
Our mission is to transform neonatal care through AI-driven, continuous monitoring that integrates audio, visual, and physiological data. By connecting care from the NICU to the home, we support timely, informed decisions across clinical environments.
-
Our Vision
To deliver a smart, integrated platform that addresses critical unmet needs in the NICU, with a focus on Neonatal Abstinence Syndrome (NAS). By combining advanced sensing and AI technology, we aim to support individualized, data-driven care for newborns.
-
Our Values
We are guided by engineering excellence, driven by innovation, and grounded in compassion. We believe that cutting-edge technology should serve real human needs and improve care for newborns to support the clinicians and families who care for them.
More about Rekovar
We use cutting edge technology to address the unmet needs from NAS babies. We automate the assessment of neonates and medication dosage delivery.
We give back to our local comminutes, hire from local universities, and provide a healthy work environment where students learn and grow.
Here at Rekovar, our goal is to reduce mortality, protect more infants, improve their quality of life, and provide consistent healthcare.
Who We Are
Founded in late 2020, Rekovar is a startup company funded by NIH - National Institute on Drug Abuse supporting scientific research on drug use and addiction.
We are currently working on a product revolutionizing neonatal care with our AI-focused, patent-pending wearable technology. Our innovative device provides real-time insights into the vital signs and symptoms of NAS, enabling healthcare professionals to deliver personalized care and intervention.
Join us as we redefine standards in healthcare and create a brighter future for babies.
